Moderna (MRNA) Capital Expenditures (2018 - 2026)
Moderna's Capital Expenditures was $37 million in Q2 2026, compared with $3 million a year earlier and down 40.3% from the prior quarter.
Moderna (MRNA) Capital Expenditures (2018 - 2026) Analysis & Trends
On a trailing twelve-month basis, Moderna's Capital Expenditures was $171 million through Jun 30, 2026, down 78.4% year-over-year; for FY2025, it came in at $192 million, down 81.7% from FY2024.
- Capital Expenditures shows a five-year compound annual growth rate of 23.1% (FY2020 to FY2025).
- In earlier years, Capital Expenditures was $1.05 billion in FY2024 (+48.7%), $707 million in FY2023 (+76.8%), $400 million in FY2022 (+40.8%) and $284 million in FY2021 (+317.6%).
- Quarterly Capital Expenditures has moved between $3 million (Q2 2025) and $522 million (Q4 2024) over five years.
- Compared with a year earlier, Capital Expenditures was higher in two of the last seven quarters, with an average decline of 30.2%.
- The best year-over-year quarter for Capital Expenditures over five years was Q3 2021 (growth of 421.1%); the worst was Q2 2025 (a decline of 98.4%).
- Per Business Quant data, MRNA's Capital Expenditures in the three quarters before Q2 2026 was $62 million (Q1 2026), $39 million (Q4 2025) and $33 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,122.91 Bn | 1,091.50 Bn | 19.71 Bn | 2.93 Bn |
| 2 | Johnson & Johnson | 615.09 Bn | 533.62 Bn | 17.26 Bn | 1.32 Bn |
| 3 | AbbVie | 504.75 Bn | 477.86 Bn | 12.70 Bn | 322.00 Mn |
| 4 | Merck | 360.18 Bn | 314.55 Bn | 12.21 Bn | 893.00 Mn |
| 5 | Novartis Ag | 292.05 Bn | 256.04 Bn | 11.24 Bn | 321.00 Mn |
| 6 | Astrazeneca | 256.09 Bn | 229.78 Bn | 12.86 Bn | 1.86 Bn |
| 7 | Amgen | 233.63 Bn | 189.02 Bn | 7.24 Bn | 513.00 Mn |
| 8 | Gilead Sciences | 194.49 Bn | 168.69 Bn | 6.22 Bn | 140.00 Mn |
| 9 | Pfizer | 168.35 Bn | 114.99 Bn | 10.94 Bn | 533.00 Mn |
| 10 | Moderna | 85.93 Bn | 65.29 Bn | 52.00 Mn | 37.00 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 37.00 Mn |
| Mar 31, 2026 | 62.00 Mn |
| Dec 31, 2025 | 39.00 Mn |
| Sep 30, 2025 | 33.00 Mn |
| Jun 30, 2025 | 3.00 Mn |
| Mar 31, 2025 | 117.00 Mn |
| Dec 31, 2024 | 522.00 Mn |
| Sep 30, 2024 | 151.00 Mn |
| Jun 30, 2024 | 182.00 Mn |
| Mar 31, 2024 | 196.00 Mn |
| Dec 31, 2023 | 220.00 Mn |
| Sep 30, 2023 | 140.00 Mn |
| Jun 30, 2023 | 234.00 Mn |
| Mar 31, 2023 | 113.00 Mn |
| Dec 31, 2022 | 92.00 Mn |
| Sep 30, 2022 | 89.00 Mn |
| Jun 30, 2022 | 87.00 Mn |
| Mar 31, 2022 | 132.00 Mn |
| Dec 31, 2021 | 120.00 Mn |
| Sep 30, 2021 | 99.00 Mn |
Moderna Capital Expenditures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-expenditures&ticker=MRNA&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-expenditures", "ticker": "MRNA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=capital-expenditures&ticker=MRNA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();